Skip to main content

Compete

Head and Neck Squamous Cell Carcinoma

xxxxx

0 Point

  • Q1. Among patients with head and neck squamous cell carcinoma treated with cisplatin and radiotherapy, which single-nucleotide polymorphism (SNP) was associated with nephrotoxicity?  
     
     
  • Q2. In a recent 2018 study on head and neck squamous cell carcinoma, the combination of the Immunoscore analysis with immunohistochemical staining for which markers of tumor-infiltrating cells aided in disease prognosis?  
     
     
  • Q3. In patients with locally aggressive or regionally metastatic cutaneous head and neck squamous cell carcinoma, high-grade PD-L1 (programmed cell death ligand 1) expression on metastases was associated with what outcome?  
     
     
  • Q4. The risk for second primary malignant neoplasms was highest in which head and neck squamous cell carcinoma (HNSCC) patient subset?  
     
     
  • Q5. In a systemic review and meta-analysis of E-cadherin expression in head and neck squamous cell carcinoma, aberrant expression of E-cadherin was associated with what outcome?  
     
     

Sign In or Register Today to Access This Content